Prognostic Value of Baseline and Soluble ST2 Change in Patients With Light Chain Cardiac Amyloidosis
Elevated baseline sST2 (>35 ng/mL) and short-term increases in sST2 predict poor prognosis in patients with light chain cardiac amyloidosis.
Authors
- Xiu‐Qing Li (ORCID: https://orcid.org/0000-0002-7308-0596)
- Jinxi Wang (ORCID: https://orcid.org/0000-0002-8653-4809)
- Ping Zhou (ORCID: https://orcid.org/0000-0003-1909-0248)
- Qiong Zhou (ORCID: https://orcid.org/0009-0007-7515-0256)
- Jian Zhang (ORCID: https://orcid.org/0000-0002-5093-4325)
- Huihui Liu (ORCID: https://orcid.org/0000-0002-4761-2800)
- Xuemei Zhao (ORCID: https://orcid.org/0000-0003-0748-8777)
- Yuhui Zhang (ORCID: https://orcid.org/0009-0000-7477-5712)
- Anran Xin
- Yan Huang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- National Health Council (US)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1161/jaha.124.040423
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00